Autoimmune diseases, immune modulation, inflammation, and self-tolerance
221 articles
Targeting immune diseases before symptoms appear can delay clinical onset by over two years, offering new prevention strategies.
New research reveals how three types of helper T cells work together to trigger harmful autoimmune responses in tissues.
Genetic variants of Epstein-Barr virus influence how well MS patients respond to interferon therapy, enabling personalized treatment.
Researchers mapped how rogue antibodies target MDA5, a critical immune protein, revealing new therapeutic targets for dermatomyositis.
New research on targeted synthetic DMARDs during pregnancy shows increased preterm birth risk but limited overall data.
Researchers analyzed 38 immune system structures to develop AI-powered, personalized treatments for autoimmune diseases.
Scientists discover how antibody feedback mechanisms control the development of long-lasting immune protection in specialized immune centers.
New research reveals how specialized immune cells in the gut could influence Parkinson's disease development and progression.
New research reveals how bacteria living inside cancer cells create immunosuppressive environments that help tumors metastasize.
Cancer immunotherapy drugs may enhance the body's natural healing processes by boosting regenerative immune responses.
New research reveals how androgens enhance monocytes' ability to provide natural pain relief through immune pathways.
Enhanced immune cells engineered with cytokines could overcome cancer's defenses and extend treatment options beyond blood cancers.
